CLDICalidi Biotherapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Calidi Biotherapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLDI본 종목 | $2M#7 | 0.0x#4 | 0.6x#5 | 40.8x#3 | — | 10.1%#7 | -44977.8%#5 | -635.4%#6 | — | — | -97.2%#3 | — |
| AIM | $5M#1 | — | 0.6x#6 | 54.1x#4 | -48.2%#4 | 19.4%#5 | -13254.5%#3 | -180.2%#5 | -7934.7%#5 | — | — | — |
| CELZ | $4M#2 | — | 0.5x#4 | 729.2x#5 | -45.5%#3 | -9.1%#8 | -102380.2%#6 | -69.3%#2 | -66.1%#2 | 3#1 | — | — |
| LIMNW | $4M#3 | — | 12.5x#8 | — | — | -187.8%#11 | — | -3395.2%#7 | -170.3%#4 | — | — | — |
| PMCB | $3M#4 | — | 0.1x#2 | — | — | -163.4%#10 | — | -70.6%#3 | -56.0%#1 | — | — | — |
| BCAB | — | — | — | — | — | 14.6%#6 | -19768.3%#4 | — | — | — | — | — |
| ESLAW | $3M#5 | — | — | — | — | — | — | — | — | — | — | — |
| CEROW | $3M#6 | — | — | — | — | — | — | — | — | — | — | 4.9%#1 |
| CRIS | $1M#8 | 0.0x#5 | 0.3x#3 | 0.1x#1 | -13.4%#2 | 82.5%#2 | -60.5%#1 | -161.5%#4 | -87.3%#3 | — | -97.9%#4 | — |
| TVGNW | $526132#9 | — | — | — | — | -91.4%#9 | — | — | — | — | 61.0%#1 | — |
| ABPWW | $116152#10 | 0.0x#3 | — | 0.6x#2 | 50.0%#1 | 60.0%#3 | -4618.6%#2 | — | — | — | -19.3%#2 | — |
| SLXNW | $99529#11 | 0.0x#2 | 2.3x#7 | — | — | 27.9%#4 | — | -27072.7%#8 | — | — | — | — |
| SABSW | $9099#12 | 0.0x#1 | 0.0x#1 | — | -100.0%#5 | 138.9%#1 | — | 6.2%#1 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice